ONEtoONE is pleased to announce that they have helped the Liège-based company CryoTherapeutics SA in securing its most recent funding of €12.3 million. The Swiss investment fund Yellowstone will now take a stake in the MedTech company. The focus of the company is the development, demonstration of clinical benefit, and early-stage commercialization of cryotherapy systems for the treatment of coronary plaque. The company´s technology is comprised of an intravascular catheter that can deliver at its tip sub-zero temperatures to treat inflamed areas of the coronary artery with the aim of stabilising lesions that could otherwise rupture and cause a heart attack. Yellowstone Holding AG (Yellowstone) is a Swiss investment company with a strong and extensive network in Asia, focusing on European med-tech start-ups with breakthrough innovation. Yellowstone is positioned as a strategic investor, aiming to bridge and integrate portfolio companies with supply chains and resources among the EU, Switzerland and Asia.